Clinical inputs
Understand the result,
not just the number.
Liver Stiffness Index (Elastography, Cardiovascular Implications): Explanation and Clinical Context Liver stiffness, measured by transient elastography, is a non-invasive marker of liver fibrosis. Elevated liver stiffness is not only associated with progression of chronic liver disease but also with increased cardiovascular risk. Multiple studies have shown that higher liver stiffness values correlate with subclinical atherosclerosis, arterial stiffness, and higher incidence of cardiovascular events in patients with metabolic syndrome, diabetes, or NAFLD.
The simplified Liver Stiffness Index calculator integrates liver stiffness (kPa), age, presence of diabetes, and hypertension to estimate relative cardiovascular risk. While not a replacement for validated CV risk calculators, it provides an adjunctive measure for clinicians to consider liver-related contributions to cardiovascular risk.
- Source 1
Castera L, et al. "Non-invasive evaluation of liver fibrosis using transient elastography." J Hepatol. 2005;43:191–198. doi:10.1016/j.jhep.2005.03.018 Targher G, et al. "Nonalcoholic fatty liver disease and risk of cardiovascular disease." Metabolism. 2010;59:135–145. doi:10.1016/j.metabol.2009.08.017 Sperandeo M, et al. "Liver stiffness measurement by transient elastography: clinical applications beyond chronic liver disease." World J Gastroenterol. 2011;17:1870–1878. doi:10.3748/wjg.v17.i15.1870
Loading discussion…